JP2022554349A5 - - Google Patents
Info
- Publication number
- JP2022554349A5 JP2022554349A5 JP2022525984A JP2022525984A JP2022554349A5 JP 2022554349 A5 JP2022554349 A5 JP 2022554349A5 JP 2022525984 A JP2022525984 A JP 2022525984A JP 2022525984 A JP2022525984 A JP 2022525984A JP 2022554349 A5 JP2022554349 A5 JP 2022554349A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- cancer
- optionally
- tcr
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025281320A JP2026053605A (ja) | 2019-11-05 | 2025-12-25 | Ｈｌａ拘束性ｈｏｒｍａｄ１ ｔ細胞受容体およびその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962930892P | 2019-11-05 | 2019-11-05 | |
| US62/930,892 | 2019-11-05 | ||
| PCT/US2020/059178 WO2021092223A1 (en) | 2019-11-05 | 2020-11-05 | Hla restricted hormad1 t cell receptors and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025281320A Division JP2026053605A (ja) | 2019-11-05 | 2025-12-25 | Ｈｌａ拘束性ｈｏｒｍａｄ１ ｔ細胞受容体およびその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022554349A JP2022554349A (ja) | 2022-12-28 |
| JP2022554349A5 true JP2022554349A5 (https=) | 2023-11-13 |
Family
ID=75848742
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022525984A Pending JP2022554349A (ja) | 2019-11-05 | 2020-11-05 | Ｈｌａ拘束性ｈｏｒｍａｄ１ ｔ細胞受容体およびその使用 |
| JP2025281320A Pending JP2026053605A (ja) | 2019-11-05 | 2025-12-25 | Ｈｌａ拘束性ｈｏｒｍａｄ１ ｔ細胞受容体およびその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025281320A Pending JP2026053605A (ja) | 2019-11-05 | 2025-12-25 | Ｈｌａ拘束性ｈｏｒｍａｄ１ ｔ細胞受容体およびその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20220409711A1 (https=) |
| EP (1) | EP4054626A4 (https=) |
| JP (2) | JP2022554349A (https=) |
| CN (1) | CN115151274B (https=) |
| CA (1) | CA3160468A1 (https=) |
| TW (1) | TW202132326A (https=) |
| WO (1) | WO2021092223A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026068511A1 (en) * | 2024-09-24 | 2026-04-02 | Universiteit Gent | Cancer immunotherapy |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6436703B1 (en) * | 2000-03-31 | 2002-08-20 | Hyseq, Inc. | Nucleic acids and polypeptides |
| US20050010030A1 (en) * | 2003-07-02 | 2005-01-13 | Zang Jingwu Z. | T cell receptor CDR3 sequence and methods for detecting and treating rheumatoid arthritis |
| US10093901B2 (en) * | 2013-05-10 | 2018-10-09 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Use of specific regulatory T-cells to induce immune tolerance |
| LT3388075T (lt) * | 2015-03-27 | 2023-11-10 | Immatics Biotechnologies Gmbh | Nauji peptidai ir peptidų deriniai, skirti naudoti imunoterapijai prieš įvairius navikus (seq id 25 - mrax5-003) |
| WO2017089786A1 (en) * | 2015-11-23 | 2017-06-01 | Immunocore Limited | Peptides |
| HRP20221183T1 (hr) * | 2016-08-02 | 2022-12-09 | The U.S.A. As Represented By The Secretary, Department Of Health And Human Services | T-stanični receptori anti-kras-g12d |
| DE102016123847B3 (de) * | 2016-12-08 | 2018-04-05 | Immatics Biotechnologies Gmbh | Neue T-Zellrezeptoren und deren Verwendung in Immuntherapie |
-
2020
- 2020-11-05 CN CN202080091441.0A patent/CN115151274B/zh active Active
- 2020-11-05 TW TW109138669A patent/TW202132326A/zh unknown
- 2020-11-05 JP JP2022525984A patent/JP2022554349A/ja active Pending
- 2020-11-05 EP EP20885490.1A patent/EP4054626A4/en active Pending
- 2020-11-05 CA CA3160468A patent/CA3160468A1/en active Pending
- 2020-11-05 US US17/774,298 patent/US20220409711A1/en active Pending
- 2020-11-05 WO PCT/US2020/059178 patent/WO2021092223A1/en not_active Ceased
-
2025
- 2025-12-25 JP JP2025281320A patent/JP2026053605A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11001621B1 (en) | Trifunctional T cell-antigen coupler and methods and uses thereof | |
| US20210379149A1 (en) | Increasing or Maintaining T-Cell Subpopulations in Adoptive T-Cell Therapy | |
| CA3126431A1 (en) | Receptors providing targeted costimulation for adoptive cell therapy | |
| TR201820015T4 (tr) | Kanser Tedavisi İçin Kimerik Antijen Reseptörü-Modifiye Edilmiş T Hücrelerinin Kullanılması | |
| JP2022554395A5 (https=) | ||
| US20230277670A1 (en) | Chimeric molecules providing targeted costimulation for adoptive cell therapy | |
| US11633427B2 (en) | Vaccine and uses thereof in cell therapy | |
| Zhang et al. | Genetic engineering with T cell receptors | |
| CN111826353A (zh) | 调节t细胞功能和反应的方法 | |
| US11981920B2 (en) | Modified cell with enhanced migration capability | |
| CN117165532A (zh) | 具有增强的迁移能力的修饰的细胞 | |
| JP2022554349A5 (https=) | ||
| CN118477171A (zh) | 脂质纳米颗粒 (lnp) 及其在细胞治疗中的用途 | |
| JP2023526416A5 (https=) | ||
| JP2024526836A5 (https=) | ||
| JP2024517630A5 (https=) | ||
| WO2024243807A1 (zh) | 靶向ny-eso-1的高亲和力t细胞受体及其应用 | |
| HK40054580A (en) | Trifunctional t cell-antigen coupler and methods and uses thereof | |
| HK1234091A1 (en) | Trifunctional t cell-antigen coupler and methods and uses thereof | |
| HK1234091B (zh) | 三功能t细胞抗原偶联物及其制备方法和用途 |